午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

Wuhan Jingkangen Biomedical Technology Co., Ltd

Firmenname:Wuhan Jingkangen Biomedical Technology Co., Ltd
Telefon:13720134139 +86 -0-15871494362
E-Mail:orders@jknbiochem.com
Nationalit?t:China
URL: www.jknbiochem.com
Produkte insgesamt:5825
4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59

Produktkatalog

Cardarine/GW501516317318-70-0C21H18F3NO3S2
Acadesine5-Amino-1-β-D-ribofuranosyl-1H-imidazol-4-carboxamid2627-69-2C9H14N4O5
Enobosarm/MK2866841205-47-8C19H14F3N3O3
Maribavir176161-24-3C15H19Cl2N3O4
LGD40331165910-22-4C14H12F6N2O
Ibutamoren mesylate/MK677159752-10-0C28H40N4O8S2
Andarine/S-4401900-40-1C19H18F3N3O6
YK11431579-34-9C25H34O6
Vosilasarm/RAD1401182367-47-0C20H16ClN5O2
SR90091379686-30-2C20H24ClN3O4S
LGD3033917891-35-1C16H14ClF3N2O
Cetuximab205923-56-4C107H179N35O36S7
Bertilimumab375348-49-5
Tuvirumab138660-97-6
Tralokinumab1044515-88-9
Ganitumab905703-97-1
Briakinumab339308-60-0
Lumiliximab357613-86-6
Infliximab170277-31-3
Research Grade Clenoliximab182912-58-9
Adecatumumab503605-66-1
Keliximab174722-30-6
Research Grade Priliximab147191-91-1
Galiximab357613-77-5
Anrukinzumab910649-32-0
Tanezumab880266-57-9
Research Grade Camidanlumab921618-45-3
Research Grade Lerdelimumab285985-06-0
Mapatumumab658052-09-6
Fresolimumab948564-73-6
Ipilimumab477202-00-9
Lexatumumab845816-02-6
Research Grade Golimumab476181-74-5
Research Grade J695
Nebacumab138661-01-5
Stamulumab705287-60-1
Metelimumab272780-74-2
Research Grade Otilimab1638332-55-4
Research Grade HuCC49823788-82-5
Gantenerumab1043556-46-2
Racotumomab946832-34-4
Catumaxomab509077-98-9
Panitumumab339177-26-3
Zalutumumab667901-13-5
Ertumaxomab509077-99-0
Conatumumab896731-82-1
Zanolimumab652153-01-0
Tenatumomab1412891-40-7
Regavirumab153101-26-9
ofatumumab679818-59-8
ocrelizumab637334-45-3C19H16N2O5
Ustekinumab815610-63-0
Efungumab762260-74-2
Oportuzumab Monatox945228-48-8
Otelixizumab881191-44-2
Etaracizumab892553-42-3
Citatuzumab Bogatox945228-49-9
Ibalizumab680188-33-4
Obinutuzumab949142-50-1
Tigatuzumab918127-53-4
Alacizumab934216-54-3
Dacetuzumab880486-59-9
notuzumab635715-01-4
Volociximab558480-40-3
Raxibacumab565451-13-0
Panobacumab885053-97-4
Tremelimumab745013-59-6
Canakinumab914613-48-2
Denosumab615258-40-7C6404H9912N1724O2004S50
Pagibaximab595566-61-3
Epitumomab372075-37-1
Iratumumab640735-09-7
Bapineuzumab648895-38-9
Tucotuzumab Celmoleukin339986-90-2
Besilesomab537694-98-7
Yttrium (90Y) Tacatuzumab Tetraxetan476413-07-7
Vapaliximab336801-86-6
Teneliximab395639-53-9
Elsilimomab468715-71-1
Erlizumab211323-03-4
Urtoxazumab502496-16-4
Pritumumab499212-74-7
Ecromeximab292819-64-8
reslizumab241473-69-8
Belimumab356547-88-1
Libivirumab569658-79-3
Robatumumab934235-44-6
Elotuzumab915296-00-3
Figitumumab943453-46-1
Research Grade Anatumomab
Research Grade Sibrotuzumab
Research Grade Taplitumomab
Cixutumumab947687-12-9
Farletuzuma896723-44-7
SU540815966-93-5C18H18N2O3
Research Grade Pintumomab
Research Grade Bivatuzumab
Lemalesomab250242-54-7
Exbivirumab569658-80-6
Tefibazumab521079-87-8
4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59
Copyright 2019 ? ChemicalBook. All rights reserved